Edition:
India

Eyenovia Inc (EYEN.OQ)

EYEN.OQ on NASDAQ Stock Exchange Capital Market

6.50USD
20 Jul 2018
Change (% chg)

$-0.09 (-1.37%)
Prev Close
$6.59
Open
$6.80
Day's High
$6.81
Day's Low
$6.38
Volume
3,310
Avg. Vol
2,456
52-wk High
$10.60
52-wk Low
$5.86

Latest Key Developments (Source: Significant Developments)

Eyenovia Reports Q1 Loss Per Share Of $0.45
Wednesday, 9 May 2018 

May 9 (Reuters) - Eyenovia Inc ::EYENOVIA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND COMPLETION OF EYN PG21 STUDY.Q1 LOSS PER SHARE $0.45.  Full Article

Eyenovia Announces Appointment Of John Gandolfo As CFO
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Eyenovia Inc ::EYENOVIA INC - APPOINTMENT OF JOHN GANDOLFO AS CHIEF FINANCIAL OFFICER EFFECTIVE DECEMBER 18, 2017.EYENOVIA ANNOUNCES APPOINTMENT OF JOHN GANDOLFO AS CHIEF FINANCIAL OFFICER.  Full Article

Eyenovia Sees IPO Of 2.73 Mln Shares Of Common Stock Priced Between $10-$12 Per Share
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Eyenovia Inc ::EYENOVIA INC SEES IPO OF 2.73 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $10.00 AND $12.00 PER SHARE - SEC FILING.EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $12 MILLION TO COMPLETE PHASE III CLINICAL TRIALS FOR MICROPROST.EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $2 MILLION TO COMPLETE PHASE III CLINICAL TRIALS FOR MICROSTAT.EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $1.5 MILLION TO COMPLETE MICROTEARS REGISTRATION ACTIVITIES.  Full Article

BRIEF-Eyenovia Reports Q1 Loss Per Share Of $0.45

* EYENOVIA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND COMPLETION OF EYN PG21 STUDY